Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01612520
NCT01612520CompletedNot Applicable

Telecoaching of People With Type 2 Diabetes in Primary Care

KU Leuven0 sites574 target enrollmentStarted: April 2012Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
KU Leuven
Enrollment
574
Primary Endpoint
the absolute change in HbA1c
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The objective of the study is to analyze the effectiveness and the cost-effectiveness of telecoching in improving glyceamic control and other modifiable risk factors in patients with type 2 diabetes compared to usual care only.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patients with type 2 diabetes between 18 and 75 years old on the day of the selection

Exclusion Criteria

  • •Debilitating coexisting medical condition (e.g. dialysis, mental illness, cancer)
  • •Residents of long term care facilities
  • •Pregnancy
  • •Incapable of telephone communication in Dutch

Outcomes

Primary Outcomes

the absolute change in HbA1c

Time Frame: baseline; 6 months and 18 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
KU Leuven
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Irina Odnoletkova

PhD Student in Biomedical sciences

KU Leuven

Similar Trials

Completed
Not Applicable
Telemedicine as a Means to Achieving Good Diabetes Control Among Patients With Type 2 DiabetesPoor Glycemic ControlMedication AdherenceType 2 Diabetes
NCT01688778Bispebjerg Hospital165
Completed
Not Applicable
Diabetes Coaching StudyType 2 Diabetes Mellitus
NCT02066831West German Center of Diabetes and Health202
Completed
Phase 3
ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.Diabetes Mellitus, Type 2
NCT00272064Sanofi352
Completed
Not Applicable
Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of LifeDiabetes Mellitus, Type 1
NCT05234944Baylor College of Medicine120
Completed
Phase 2
Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound ManagementDiabetesDiabetic Foot Ulcer
NCT01814267University Hospital, Grenoble14
Telecoaching of People With Type 2... | Clinical Trial